Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

LadaTech Patent Infringed by Illumina, Federal Jury Rules
Bloomberg
Friday, March 2, 2012 - 10:11am
tags:
LadaTech, patents, Illumina, GSK, gene manipulation
Charles River Laboratories International Crushes Earnings Estimates
Motley Fool
Friday, March 2, 2012 - 10:10am
tags:
earnings, Charles River Laboratories
Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
TheStreet.com
Friday, March 2, 2012 - 10:10am
tags:
Cyclacel, Vivus, Celldex, Astex, Discovery Labs, Exelixis
[video] The Next Big Thing in Biotech: Discovery Labs
TheStreet.com
Friday, March 2, 2012 - 10:07am
tags:
Discovery Labs
Anika Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Friday, March 2, 2012 - 10:07am
tags:
earnings, Anika
Teva Pharmaceutical: Dividends, Earnings And Valuation Analysis
Seeking Alpha
Friday, March 2, 2012 - 9:50am
tags:
Teva Pharmaceuticals, earnings, dividends
SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results
Yahoo/AP
Friday, March 2, 2012 - 9:49am
tags:
SciClone, head and neck cancer, SCV-07, oral mucositis
Watson launches generic version of Abbott's Prometrium
Yahoo/Fly on the Wall
Friday, March 2, 2012 - 9:48am
tags:
generics, Abbott Laboratories, Prometrium
Judge refuses to halt Amgen-Micromet deal
Yahoo/AP
Thursday, March 1, 2012 - 6:03pm
tags:
Amgen, Micromet, M&A
Durect's partner Pfizer to end pain drug deal
Reuters
Thursday, March 1, 2012 - 6:02pm
tags:
Pfizer, Durect Corporation, Eladur
Pharmacyclics Gains Ahead of Investor Call
Bloomberg
Thursday, March 1, 2012 - 5:59pm
tags:
Pharmacyclics, JNJ
Recent FDA Approval Makes Vertex A Ripe Target For Takeover
Seeking Alpha
Thursday, March 1, 2012 - 12:45pm
tags:
FDA, Vertex, M&A, Kalydeco, cystic fibrosis
Spectrum Pharma 4Q profit grows, but shares fall
Yahoo/AP
Thursday, March 1, 2012 - 12:44pm
tags:
Spectrum Pharmaceuticals, earnings
Endo Pharmaceuticals to Change Name to Endo Health Solutions
Bloomberg
Thursday, March 1, 2012 - 12:43pm
tags:
Endo Health Solutions, Endo
Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Thursday, March 1, 2012 - 12:42pm
tags:
Allos, earnings
What BioSante's Balance Sheet Says About Future R&D
Seeking Alpha
Thursday, March 1, 2012 - 12:42pm
tags:
BioSante, R&D
Avanir: Addressing The Strength Of Nuedexta's Patents; Imminent Short Squeeze
Seeking Alpha
Thursday, March 1, 2012 - 12:35pm
tags:
Avanir, Nuedexta, PBA
Mylan begins selling lower-cost generic version of Forest Lab's antidepressant Lexapro
Yahoo/AP
Thursday, March 1, 2012 - 12:34pm
tags:
Mylan, Lexapro, generics, Forest Labs, antidepressants
US patent office rejects Amarin's patent application
Reuters
Thursday, March 1, 2012 - 12:34pm
tags:
Amarin, patents, AMR101
Parkinson’s Drug Helps Speed Recovery After Brain Trauma, Researchers Say
Bloomberg
Thursday, March 1, 2012 - 12:33pm
tags:
Parkinson's Disease, brain injury, brain trauma, amantadine

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.